Cargando…
A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells
BACKGROUND: Transferrin receptor (TfR) is a cell membrane-associated glycoprotein involved in the cellular uptake of iron and the regulation of cell growth. Recent studies have shown the elevated expression levels of TfR on cancer cells compared with normal cells. The elevated expression levels of t...
Autores principales: | Kawamoto, Megumi, Horibe, Tomohisa, Kohno, Masayuki, Kawakami, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167775/ https://www.ncbi.nlm.nih.gov/pubmed/21849092 http://dx.doi.org/10.1186/1471-2407-11-359 |
Ejemplares similares
-
Synergetic cytotoxic activity toward breast cancer cells enhanced by the combination of Antp-TPR hybrid peptide targeting Hsp90 and Hsp70-targeted peptide
por: Horibe, Tomohisa, et al.
Publicado: (2014) -
Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells
por: Horibe, Tomohisa, et al.
Publicado: (2012) -
Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent
por: Horibe, Tomohisa, et al.
Publicado: (2011) -
Targeting Interleukin-4 Receptor Alpha by Hybrid Peptide for Novel Biliary Tract Cancer Therapy
por: Seto, Kahori, et al.
Publicado: (2014) -
Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma
por: Kikuchi, Osamu, et al.
Publicado: (2016)